Insmed Inc (INSM)
73.15
-0.66
(-0.89%)
USD |
NASDAQ |
Nov 22, 16:00
73.10
-0.05
(-0.07%)
After-Hours: 20:00
Insmed Total Return Price: 73.15 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 73.15 |
November 21, 2024 | 73.81 |
November 20, 2024 | 72.67 |
November 19, 2024 | 73.72 |
November 18, 2024 | 66.61 |
November 15, 2024 | 66.29 |
November 14, 2024 | 71.26 |
November 13, 2024 | 70.60 |
November 12, 2024 | 70.14 |
November 11, 2024 | 71.82 |
November 08, 2024 | 73.54 |
November 07, 2024 | 71.69 |
November 06, 2024 | 72.86 |
November 05, 2024 | 69.30 |
November 04, 2024 | 68.09 |
November 01, 2024 | 68.32 |
October 31, 2024 | 67.28 |
October 30, 2024 | 70.30 |
October 29, 2024 | 70.95 |
October 28, 2024 | 71.96 |
October 25, 2024 | 70.96 |
October 24, 2024 | 71.71 |
October 23, 2024 | 71.94 |
October 22, 2024 | 73.68 |
October 21, 2024 | 72.28 |
Date | Value |
---|---|
October 18, 2024 | 74.54 |
October 17, 2024 | 74.27 |
October 16, 2024 | 76.65 |
October 15, 2024 | 74.66 |
October 14, 2024 | 75.08 |
October 11, 2024 | 74.56 |
October 10, 2024 | 71.70 |
October 09, 2024 | 69.96 |
October 08, 2024 | 71.37 |
October 07, 2024 | 70.50 |
October 04, 2024 | 72.27 |
October 03, 2024 | 71.40 |
October 02, 2024 | 73.02 |
October 01, 2024 | 72.88 |
September 30, 2024 | 73.00 |
September 27, 2024 | 72.48 |
September 26, 2024 | 72.87 |
September 25, 2024 | 72.74 |
September 24, 2024 | 72.63 |
September 23, 2024 | 71.82 |
September 20, 2024 | 74.21 |
September 19, 2024 | 74.97 |
September 18, 2024 | 72.87 |
September 17, 2024 | 73.26 |
September 16, 2024 | 73.23 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
13.63
Minimum
Mar 23 2020
79.01
Maximum
Aug 22 2024
30.25
Average
26.00
Median
Jul 24 2020
Total Return Price Benchmarks
Alnylam Pharmaceuticals Inc | 244.89 |
Amicus Therapeutics Inc | 9.66 |
Collegium Pharmaceutical Inc | 29.96 |
enVVeno Medical Corp | 3.41 |
Fulcrum Therapeutics Inc | 3.25 |